4.7 Article

Role of the Cys154Arg Substitution in Ribosomal Protein L3 in Oxazolidinone Resistance in Mycobacterium tuberculosis

期刊

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 60, 期 5, 页码 3202-3206

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00152-16

关键词

-

资金

  1. One Hundred Talents Program of the Chinese Academy of Sciences
  2. Key Program of the Chinese Academy of Sciences [KJZD-EW-L02]
  3. National Natural Science Foundation of China [81572037]
  4. State Key Lab of Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University [2015SKLRD-K01, 2014SKLRD-O06]
  5. Chinese Academy of Sciences-Commonwealth Scientific and Industrial Research Organization Joint Grant [154144KYSB20150045]
  6. Guangzhou Municipal Industry and Research Collaborative Innovation Program [201508020248]
  7. Guangzhou Municipal Clinical Medical Center Program [155700012]

向作者/读者索取更多资源

We expressed the wild-type rplC and mutated rplC (Cys154Arg) genes, respectively, in Mycobacterium tuberculosis H37Ra and H37Rv in an attempt to delineate the role of rplC (Cys154Arg) regarding oxazolidinone resistance. An increase of the MICs of linezolid (LZD) and sutezolid (PNU-100480, PNU) against the recombinant mycobacteria with overexpressed rplC mutation (Cys154Arg) was found, suggesting the rplC gene is a determinant of bacillary susceptibilities to LZD and PNU.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据